U.S. Markets open in 4 hrs, 44 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,955.50 | -369.88 | -3.58% |
| NASDAQ | 1,862.96 | -84.43 | -4.34% |
| S&P 500 | 1,056.89 | -42.34 | -3.85% |
| Day Low 02:32 PM EDT | 8.14 | |
|---|---|---|
| Day High 11:36 AM EDT | 9.18 |
|
| Range | 1.04 | |
| Volume | 812,180 | |
| 30-Day Avg. Vol. | 518,000 |
|
| Difference | 56.79% | |
| Market Cap. | 690.51 M | |
| Change | -8.76 M | |
| Shares Out. | 79.64 M | |
| Percent Traded | 1.02% | |
| Revenue (LFY) | 22.42 M | |
| Earnings (TTM) | -48.93 M | |
| Next Earnings | 02/02/2009 |
|
| EPS (TTM) | -0.88 |
| 52-Wk Low 1/22/08 | 7.20 | |
|---|---|---|
| 52-Wk High 12/4/07 | 13.44 |
|
| Range | 6.24 | |
| Prev. Close 10/3/08 | 8.78 | |
| Today's Open | 8.70 | |
| Change | -0.91% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.9479 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -8.00 |
Seattle Genetics is working on monoclonal antibodies (MAbs) to treat a variety of cancers and autoimmune diseases. It is developing MAbs potent enough to fight cancer on their own, as well as those used ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.183 3/31/08 | -0.22 3/31/08 |
-0.037
Missed
|
| Last Quarter | -0.266 6/30/08 | -0.20 6/30/08 |
0.066
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 10.00 M | 22.42 M |
| Gross Profit | 9.17 M | 19.87 M |
| Operating Income | -17.59 M | -55.64 M |
| Net Income | -16.03 M | -48.93 M |
